The global enteral collagen peptide protein market was valued at $14,586 thousand in 2020, and is projected to reach $25,811 thousand by 2030, registering a CAGR of 7.2% from 2021-2030. Collagen peptide protein is a protein derived from animal collagen. Enteral collagen peptide protein is a rich source of healthy nutrients that is prescribed to patients who are unable to consume sufficient nutrients orally, but whose gastrointestinal function is in a satisfactory condition for digestion and absorption. This process is deployed when a patient is unable to eat due to some illness, has swallowing difficulties, or has underwent surgery that may interfere with the normal eating process. In this process, collagen peptides protein is administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes.
Rise in the prevalence of chronic illness such osteoarthritis and cardiovascular diseases and increase in applications of collagen peptide protein in the healthcare sector are the major factors driving the growth of the global enteral collagen peptide protein market. Furthermore, increase in geriatric population along with favorable government initiates to promote healthy diet among population are expected to provide lucrative opportunities for existing players and new entrants. However, poor demand and lack of awareness of enteral collagen peptide protein products in underdeveloped countries hamper the market growth. Conversely, high growth potential in untapped emerging economies is expected to provide new avenues for the expansion of the global market during the forecast period.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The COVID-19 pandemic is an unprecedented global public health challenge, and is anticipated to have a negative impact on enteral collagen peptide protein market, owing to decline in meat consumption, especially marine and bovine products, across the globe. This factor has directly impacted the production of collagen peptides, as fish and beef wastes are major raw materials for collagen products. In addition, business collaborations and partnership opportunities for enteral collagen peptide protein are negatively affected by COVID-19 outbreak, which led to decline in the enteral collagen peptide protein products production. Thus, the enteral collagen peptide protein market has been negatively impacted due to the current global health crisis
Enteral Collagen Peptide Protein Market Segmentation
The global enteral collagen peptide protein market is segmented into form, age group, end user, and region. On the basis of form, the enteral collagen peptide protein market is bifurcated into powder and liquid. By age group, it is classified into adults (above 18) and pediatrics (below 18). Depending on end user, it is fragmented into hospitals & clinics, homecare, and nursing home. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment review
On the basis of form, the liquid segment is the major revenue contributor, and is projected to grow significantly during the forecast period, owing to increase in the demand and consumption of enteral supplements that come in the form of liquid, due to increase in availability of liquid enteral collagen peptide protein products and rise in health concerns among consumers.
By Form
Liquid segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
On the basis of age group, the adult (above 18 years) segment was the major revenue contributor, and is projected to grow significantly during the forecast period. This is attributed to higher number of patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis. Furthermore, increase in geriatric population that requires enteral collagen peptide protein and has difficulty in swallowing is expected to contribute toward the market growth.
By Age Group
Age Group Segment hold the dominant position and would continue to maintain the lead over the forecast period.
By end user, the homecare segment is the major shareholder in the enteral collagen protein peptide market, owing to increase in number of patients adopting enteral collagen peptide protein products administration at home and increase in demand for home care enteral collagen peptide protein treatment.
By End User
Home Care Segment hold the dominant position and would continue to maintain the lead over the forecast period.
Snapshot of Asia-Pacific enteral collagen peptide protein market
Asia-Pacific presents lucrative opportunities for key players operating in the enteral collagen peptide protein market, owing to increase in geriatric population, R&D investments in developments of collagen peptide protein products for various chronic diseases, supportive government initiatives directed toward the reduction of the malnutrition deficiency, and significant surge in demand for advanced healthcare facilities.
By Country
Asia Pacific exhibit the highest CAGR of 9.2 % during 2021-2030
Moreover, rise in number of people suffering from arthritis disease and surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share are expected to drive growth of the enteral collagen peptide protein market in the region.
The key players profiled in this report include Abbott laboratories, Danone S.A (Nutricia). Dermarites Industries LLC, Medtronic, Inc, Medline Industries, Inc, Global Health Products, Inc., OP2 labs, LLC, fresenius Kabi AG, Gelita AG, and Weishardt Holding SA.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the enteral collagen peptide protein market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers enteral collagen peptide protein market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global enteral collagen peptide protein market growth.
Key Market Segments
By Form
- Powder
- Liquid
By Age Group
- Adults (Above 18)
- Pediatrics (Below 18)
By End User
- Hospitals & Clinics
- Homecare
- Nursing Home
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Enteral Collagen Peptide Protein Market Report Highlights
| Aspects | Details |
 By FORM |
|
 By AGE GROUP |
|
 By END USER |
|
 By Region |
|
 Key Market Players | GELITA AG, WEISHARDT HOLDING SA, DANONE S.A. (NUTRICIA), .FRESENIUS KABI AG, DERMARITE INDUSTRIES LLC, MEDLINE INDUSTRIES, INC., ABBOTT LABORATORIES, OP2 LABS LLC, GLOBAL HEALTH PRODUCTS, INC., MEDTRITION INC. |
Analyst Review
Enteral collagen peptide protein is recommended for patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis. In enteral feeding system, nutrition or medications are directly administered in the stomach or intestine.
Factors such as rise in sale of enteral collagen peptide protein products, consumer focus on protein-rich diets, and rise in use of collagen peptide protein in the healthcare industry due to their high protein content drive the growth of market. In addition, increase in investment in R&D activities to develop innovative products and rise in number of malnutrition cases drives the growth of the market. Moreover, surge in geriatric population and favorable government initiatives to promote healthy diet among population. However, poor demand and lack of awareness of enteral collagen peptide protein products in underdeveloped countries hamper the market growth during the forecast period.
The total market value of Enteral Collagen Peptide Protein Market is $ 25,811 Thousand in 2020
The forecast period in the report is from 2021 to 2030
The market value of Enteral Collagen Peptide Protein in 2020 was 14,586 Thousand
The base year for the report is 2020
Yes, Enteral Collagen Peptide Protein Market companies are profiled in the report
The top companies that hold the market share in Enteral Collagen Peptide Protein Market are are Abbott laboratories, Danone S.A (Nutricia). Dermarites Industries LLC, Medtronic, Inc, Medlin Industries
No, there is no value chain analysis provided in the Enteral Collagen Peptide Protein Market report
The key trends in the Enteral Collagen Peptide Protein Market are increase in number of patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis and increase in demand for home care enteral collagen peptide protein treatment
Loading Table Of Content...
